Strategy Document — February 2026
Practical use cases from data collection to publication — with Claude Code, Chinese open-source models, and public health datasets. Every step that normally costs money or months of time.
Editor-in-Chief: Samuel Wong Yeung Shan · The Jockey Club School of Public Health and Primary Care · The Chinese University of Hong Kong
01 — Overview
Every step of the academic publication process can be accelerated with AI. Here is the complete workflow that Claude Code (and alternatives) can cover for APJLM:
02 — Research & Data
A recent study published in Annals of Internal Medicine (2025) demonstrated: Claude-based data extraction achieves 91.0% accuracy across 9,341 data points — outperforming purely human extraction (89.0%). Per paper, it saves approximately 41 minutes.
In a separate oncology SLR study, Claude 3.7 Sonnet extracted 117,889 data points across 106 variables with 98.2% precision and 96.6% recall.
With Claude Code as your workflow engine: search PubMed/Scopus, screen abstracts, analyze full texts, generate PRISMA diagrams, create risk-of-bias tables. All from a single terminal.
The GBD 2021 dataset contains NCD data across 204 countries and 811 subnational regions. Claude Code can directly tap the GBD Results API, filter data for the Asia-Pacific region, and generate publication-ready comparison tables and trend analyses.
China alone accounts for 25.9% of global NCD deaths despite being 17.9% of the world population. The provincial-level data across 31 Chinese provinces offers enormous analytical potential.
Claude Code can automatically scan arXiv, PubMed, and preprint servers daily, detect emerging trends in lifestyle medicine, and deliver a monthly "Emerging Topics Report" to the editorial board — as the basis for Call for Papers and Special Issues.
This gives APJLM a first-mover advantage on topics that larger journals may take months to notice.
03 — Writing & Drafting
Claude Code can create journal-specific templates for APJLM. Authors upload their data and notes → Claude generates a complete IMRaD draft with correct sections, formatting, and reference placeholders.
Important: The human remains the author. AI is the co-pilot — it accelerates but does not replace scientific thinking and domain expertise.
Many excellent researchers in the Asia-Pacific region don't have English as their first language. AI can:
→ Polish academic English without changing the content or meaning
→ Translate abstracts into local languages (for regional visibility)
→ Summarize Chinese-language research reports and extract key data points
→ Help Thai, Sinhalese, Vietnamese researchers write at native-English quality
Claude Code generates publication-ready visualizations directly from datasets: forest plots, Kaplan-Meier curves, heatmaps, geographic maps (Asia-Pacific NCD distribution), PRISMA flowcharts — all in Python/R, exported as high-resolution graphics.
No need to hire a graphic designer or statistician for standard academic figures.
04 — Editorial Workflow
With editorial board members committing just 2–4 hours per month, every minute counts. AI can multiply the effectiveness of that limited time dramatically.
Before an editor even reads a paper, Claude can perform an automated quality pre-check: Is the paper thematically relevant? Is the structure correct? Are there obvious statistical issues? Plagiarism indicators? Are references current?
Output: A one-page summary for the editor with a recommendation (Desk Reject / Send to Review / Minor Issues to Address).
Claude searches author databases (Scopus, ORCID, Semantic Scholar) for appropriate reviewers based on the paper's topic and methodology. It generates personalized invitation emails, suggests backup reviewers if someone declines, and tracks responses.
Finding the right reviewers is one of the most time-consuming editorial tasks. AI reduces this from hours to minutes.
Three reviewers submit 2-page reports each. Claude consolidates them: identifies common critique points, flags contradictions between reviewers, and proposes a decision matrix — so the editor can decide faster and more thoroughly.
AI generates professional, personalized correspondence for every stage: acknowledgment of submission, reviewer invitations, revision requests with specific action points, acceptance/rejection letters. Each tailored to the specific paper and situation, not generic boilerplate.
05 — China Strategy
China has the world's largest NCD data pool with 1.4 billion people. NCDs account for 91% of all deaths in China — 10.6 million NCD deaths per year, representing 25.9% of global NCD mortality. Simultaneously, China is now the global leader in open-source AI models. This combination is an enormous opportunity for APJLM.
China Chronic Disease and Risk Factor Surveillance. 732,472 adults across 6 waves (2004–2018). Blood pressure, glucose, lipids, BMI, lifestyle factors across 31 provinces.
Global Burden of Disease — China-specific data for all 31 provinces, 1990–2021. NCDs, DALYs, risk factors. Detailed subnational breakdowns.
China National Nutrition Survey. Nutrition data, physical activity, obesity trends. Waves in 2002, 2010–2013, 2015, and 2020.
China Health and Retirement Longitudinal Study. Ageing & health in adults 45+. ~17,000 individuals, internationally comparable (linked to HRS, SHARE, ELSA).
China's first provincial-level real-world data platform in the Boao Lecheng pilot zone. Clinical data for regulatory and research purposes.
A scoping review (PMC, 2022) identified 70 nationwide health databases in China — 20 specifically covering NCDs (stroke, AMI, cancer, rare diseases). Most accessible via application.
Open-source reasoning model. Free. Excellent for data analysis, coding, and academic writing. Low hallucination rate (2.4%). Rivals GPT-4o on many benchmarks.
Alibaba's model family. #1 on Hugging Face by downloads (over 40% of all new model derivatives). Best performance for Chinese academic text. Outperforms GPT-4o on medical queries.
ByteDance's AI assistant with 570 million users in China. Potentially useful for distributing APJLM content and summaries in the Chinese market.
The idea: APJLM becomes the first lifestyle medicine journal to systematically make Chinese open data sources accessible for international publications. The workflow:
1. Qwen processes Chinese-language research reports and datasets (best-in-class for Chinese text)
2. Claude Code prepares the data for international analysis (statistics, visualization, English output)
3. Human experts provide domain knowledge and scientific interpretation
4. APJLM publishes — as the unique channel making this data available to the international audience
Healthcare is already the most competitive area for generative AI in China, with companies like SenseTime, Tencent, Alibaba, iFlyTek, Baichuan, and ByteDance all building health-focused AI tools. Partnering with these ecosystems positions APJLM at the intersection of the two biggest trends in Asia-Pacific health research: massive NCD data availability and AI-powered analysis.
06 — Tool Overview
| Task | Best Tool | Cost |
|---|---|---|
| Data analysis & code generation | Claude Code (writes Python/R directly) | $20/mo Pro |
| Systematic review screening | Claude + ASReview (open source) | $20/mo + Free |
| Processing Chinese texts | Qwen 2.5 (best Chinese-language model) | Free |
| Statistical analysis | Claude Code + R/Python packages | $20/mo |
| Paper writing (English) | Claude (highest text quality) | $20/mo |
| Figures & visualizations | Claude Code (matplotlib, ggplot2, seaborn) | $20/mo |
| Heavy coding / automation | DeepSeek R1 (free, strong at code) | Free |
| Peer review support | Claude (strongest at methodological critique) | $20/mo |
| Abstract translation | Claude / Qwen depending on language | $20/mo / Free |
| Social media & outreach | Claude (lay summaries, thread writing) | $20/mo |
| Scientific paper writing plugin | claude-scientific-writer (GitHub, open source) | Free |
07 — Impact
| Task | Without AI | With AI |
|---|---|---|
| Systematic review (60 papers) | 6 months, 2 researchers | 3–4 weeks, 1 person |
| Data extraction per paper | ~240 minutes | ~4.5 minutes (+ human review) |
| Paper draft writing | 4–8 weeks | 1–2 weeks |
| Pre-screening a manuscript | 45 min per editor | 15 min (AI pre-screen) |
| Figure creation | $500–2,000 per graphic designer | $0 (Claude Code) |
| Language editing (ESL authors) | $300–800 per paper | $0 (AI) + human review |
| Finding & inviting reviewers | 2–5 hours | 20 minutes |
| GBD data analysis (country comparison) | Hire a statistician | Claude Code in 2 hours |
| Monthly trend report for board | Doesn't exist | Automated, delivered monthly |
A small journal like APJLM can achieve the productivity of a team 5–10× its actual size using AI tools. The investment: $20–40/month for Claude Pro plus free open-source tools (DeepSeek, Qwen, ASReview). This enables:
→ More and better publications per year — AI removes bottlenecks in every stage of the pipeline
→ Faster review cycles — making the journal more attractive to authors
→ Unique China-data papers as a USP — no other lifestyle medicine journal does this systematically
→ Relief for the editorial board — when you only have 2–4 hours/month, every minute counts
→ Competitive advantage over established journals with 10× more budget but slower AI adoption
The biggest opportunity is the China–APJLM Data Bridge: combining the world's largest NCD dataset with the world's best Chinese-language AI models, published through an Asia-Pacific–focused journal. That's a combination nobody else is doing.